News

Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated in the treatment

Atacand is an angiotensin II receptor blocker (ARB) indicated for the treatment of hypertension in adults and children 1 to <17 years of age, to lower blood pressure.

The transaction amount includes Sucampo’s debt of $360m assumed by the UK-based Mallinckrodt. Amitiza (lubiprostone) has the approvals of the US Food and Drug Administration (FDA) for three

Summit retains commercialisation rights in all other countries. Ridinilazole is a targeted antibiotic that has the potential as a frontline therapy to treat initial infection and preserve patients'

The European Commission has approved Alecensa (alectinib) as first-line treatment in ALK-positive lung cancer, while the US Food and Drug Administration (FDA) approved Perjeta (pertuzumab), in combination with Herceptin (trastuzumab) and

Under the agreement, vTv has granted Huadong Pharmaceutical an exclusive license to develop, manufacture and commercialize vTv Therapeutics’ GLP-1r agonist program in China, Hong Kong, Macau, Taiwan, Thailand,

"We look forward to collaborating with bluebird bio to bring to market breakthrough therapies to fight diseases for which there are limited or no options," said Udit Batra,

This ongoing study evaluated upadacitinib (ABT-494), an investigational oral JAK1-selective inhibitor, as a monotherapy treatment in patients with moderate to severe rheumatoid arthritis (RA) who did not adequately

The two companies have entered into a collaboration for a phase 1b study to combine TAR-200 (GemRIS) with Bristol-Myers' Opdivo (nivolumab) to treat muscle invasive bladder cancer. The trial will assess